- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-1-1-mer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.2: 14 residues within 4Å:- Chain A: E.216, P.217, V.259, L.266, N.267, F.380, N.381, C.382, G.383, R.447, C.448, V.449, S.450
- Ligands: NAG.14
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:G.383, A:V.449
NAG-NAG-BMA.4: 10 residues within 4Å:- Chain D: E.216, P.217, V.259, L.266, N.267, F.380, G.383, V.449, S.450
- Ligands: NAG.28
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.5: 13 residues within 4Å:- Chain F: E.216, P.217, V.259, L.266, N.267, F.380, N.381, C.382, G.383, C.448, V.449, S.450
- Ligands: NAG.46
1 PLIP interactions:1 interactions with chain F- Hydrogen bonds: F:G.383
- 43 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.6: 5 residues within 4Å:- Chain A: E.92, N.93
- Chain B: A.14, G.16, S.17
Ligand excluded by PLIPNAG.7: 5 residues within 4Å:- Chain A: S.155, F.156, N.157, K.166, K.168
Ligand excluded by PLIPNAG.8: 4 residues within 4Å:- Chain A: R.197, N.202, T.203
- Chain D: R.313
Ligand excluded by PLIPNAG.9: 9 residues within 4Å:- Chain A: N.239, T.241, G.242, P.243, I.277, R.278, S.279, I.282, H.356
Ligand excluded by PLIPNAG.10: 4 residues within 4Å:- Chain A: H.90, K.234, T.245, N.246
Ligand excluded by PLIPNAG.11: 3 residues within 4Å:- Chain A: N.281, T.283, N.284
Ligand excluded by PLIPNAG.12: 6 residues within 4Å:- Chain A: N.367, S.368, S.369, T.376, S.392
- Ligands: NAG.13
Ligand excluded by PLIPNAG.13: 5 residues within 4Å:- Chain A: T.377, N.390, S.392
- Ligands: NAG.12, NAG.17
Ligand excluded by PLIPNAG.14: 5 residues within 4Å:- Chain A: K.257, N.267, S.296, N.451
- Ligands: NAG-NAG-BMA.2
Ligand excluded by PLIPNAG.15: 7 residues within 4Å:- Chain A: Q.298, N.300, N.336, V.337, S.338, S.416, R.447
Ligand excluded by PLIPNAG.16: 1 residues within 4Å:- Chain A: N.359
Ligand excluded by PLIPNAG.17: 4 residues within 4Å:- Chain A: S.392, G.393, N.396
- Ligands: NAG.13
Ligand excluded by PLIPNAG.18: 3 residues within 4Å:- Chain A: K.339, A.340, N.343
Ligand excluded by PLIPNAG.19: 4 residues within 4Å:- Chain B: P.98, W.99, N.100, T.102
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain B: E.123, N.126, Y.127
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain C: K.122, E.123, N.126
Ligand excluded by PLIPNAG.22: 5 residues within 4Å:- Chain D: Q.135, S.155, F.156, N.157, K.168
Ligand excluded by PLIPNAG.23: 5 residues within 4Å:- Chain D: W.101, N.239, G.240, T.241, S.279
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain D: N.281, N.284, N.285
Ligand excluded by PLIPNAG.25: 1 residues within 4Å:- Chain D: N.306
Ligand excluded by PLIPNAG.26: 7 residues within 4Å:- Chain D: N.300, C.301, T.302, H.334, C.335, N.336
- Ligands: NAG.29
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain D: N.343, V.350
Ligand excluded by PLIPNAG.28: 6 residues within 4Å:- Chain D: N.267, S.296, V.449, S.450, N.451
- Ligands: NAG-NAG-BMA.4
Ligand excluded by PLIPNAG.29: 5 residues within 4Å:- Chain D: Q.298, N.300, S.338, V.449
- Ligands: NAG.26
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain D: T.376, T.377, N.390, T.391
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain E: N.100, S.101, T.102
Ligand excluded by PLIPNAG.32: 6 residues within 4Å:- Chain E: K.122, E.123, I.124, S.125, N.126, Y.127
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain F: E.92, N.93
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain F: Q.135, N.157, K.166
Ligand excluded by PLIPNAG.35: 6 residues within 4Å:- Chain F: V.139, N.141, N.153, S.155, Y.170, L.172
Ligand excluded by PLIPNAG.36: 5 residues within 4Å:- Chain A: R.313, W.319
- Chain F: V.179, N.202, T.203
Ligand excluded by PLIPNAG.37: 7 residues within 4Å:- Chain F: N.239, T.241, G.242, S.279, E.280, N.281, I.282
Ligand excluded by PLIPNAG.38: 4 residues within 4Å:- Chain F: H.90, K.234, T.245, N.246
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain F: N.281, T.283, N.284
Ligand excluded by PLIPNAG.40: 4 residues within 4Å:- Chain F: E.274, N.294, E.295, K.348
Ligand excluded by PLIPNAG.41: 6 residues within 4Å:- Chain F: Q.298, I.299, N.300, N.336, V.337, S.338
Ligand excluded by PLIPNAG.42: 9 residues within 4Å:- Chain F: N.300, C.301, T.302, H.334, C.335, N.336, S.416, T.418, R.447
Ligand excluded by PLIPNAG.43: 4 residues within 4Å:- Chain F: R.354, N.359, N.360, S.401
Ligand excluded by PLIPNAG.44: 5 residues within 4Å:- Chain F: N.367, S.368, S.392, N.396
- Ligands: NAG.45
Ligand excluded by PLIPNAG.45: 7 residues within 4Å:- Chain F: N.367, T.376, T.377, N.390, T.391, S.392
- Ligands: NAG.44
Ligand excluded by PLIPNAG.46: 5 residues within 4Å:- Chain F: K.257, N.267, S.296, N.451
- Ligands: NAG-NAG-BMA.5
Ligand excluded by PLIPNAG.47: 7 residues within 4Å:- Chain F: T.137, N.138, T.140, R.148, G.149, K.152, Y.196
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain F: N.306, I.327, V.445
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cottrell, C.A. et al., Priming antibody responses to the fusion peptide in rhesus macaques. Npj Vaccines (2024)
- Release Date
- 2024-06-12
- Peptides
- Surface protein gp120: ADF
Transmembrane protein gp41: BCE
N289 Heavy Chain: G
N289 Light Chain: H - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
EF
FB
BC
CE
DG
HH
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-1-1-mer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 43 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cottrell, C.A. et al., Priming antibody responses to the fusion peptide in rhesus macaques. Npj Vaccines (2024)
- Release Date
- 2024-06-12
- Peptides
- Surface protein gp120: ADF
Transmembrane protein gp41: BCE
N289 Heavy Chain: G
N289 Light Chain: H - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
EF
FB
BC
CE
DG
HH
L